Posts in tag

SmallCap


Cardiff Oncology (CRDF)  is a small oncology company whose shares have been caught in the biotech selloff through the first six months of 2022. Now, at CRDF’s current trading levels, I see the stock as setup for a compelling risk/reward trade. In fact, with the right option strategy, you can get your potential entry level down to significantly below the …

ENGLEWOOD, Colo., April 26, 2021 /PRNewswire/ — Lightwave Logic, Inc. (OTCQX: LWLG), a technology platform company leveraging its proprietary electro-optic polymers to transmit data at higher speeds with less power, today announced that management attended EPIC’s Online Technology Meeting on PIC Packaging taking place virtually April 26, 2021. Lightwave Logic CEO Dr. Michael Lebby led a …

NEW YORK, Feb. 10, 2021 /PRNewswire/ — Amkor Technology Inc. (NASD: AMKR) will replace HNI Corp. (NYSE: HNI) in the S&P MidCap 400 and HNI Corp will replace Virtusa Corp. (NASD: VRTU) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, February 16. Baring Private Equity Asia is acquiring Virtusa …

NEW YORK, Sept. 4, 2020 /PRNewswire/ — The diagnostics industry is a large and varied market, with new and innovative technology constantly being introduced. There are also various types of diagnostic methods including In Vitro Diagnostics (IVD), Point of Care (POC), Molecular diagnostics, genomic diagnostics and others. Overall, a major factor contributing to the growth of …

NEW YORK, June 12, 2020 /PRNewswire/ — S&P Dow Jones Indices will make the following index adjustments to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 to ensure each index more appropriately represents its market capitalization range. The changes will be effective prior to the open of trading on Monday, June 22 to …

Today, we will see why Sol-Gel Technologies (SLGL) is a promising small-cap dermatology pick for 2020. Company overview Sol-Gel Technologies Ltd. is a clinical-stage dermatology company focused on becoming leaders in the treatment of acne and rosacea. Sol-Gel Technologies has two investigational branded products, TWIN and Epsolay, as well as multiple generic product candidates targeting …

PHOENIX, Jan. 5, 2020 /PRNewswire/ — Alpine 4 Technologies (OTCQB: ALPP) announced today that it is providing preliminary guidance for its 2019 revenue. The company expects to report for 2019 sales of $28 million, which is revenue growth of approximately 96% over 2018. Kent B. Wilson, Alpine 4 CEO, had this to say: “In 2019, we advanced on …

NEW YORK, Nov. 15, 2019 /PRNewswire/ — Recon Technology, Ltd. (NASDAQ:RCON) (“Recon” or the “Company”), today announced that Sinopec Huabei Oilfield Branch Oil Extraction First Factory (“Huabei Oilfield”), a client of Recon’s wholly-owned subsidiary Beijing Bright Petroleum Technology Co., Ltd (“Beijing BHD”), recently received a wastewater test report, showing all the indicators of the sample wastewater …

Oral thin films provide a convenient and accurate delivery system with increased bioavailability of cannabis active ingredients for patients LAS VEGAS, June 11, 2019 /PRNewswire/ — GB Sciences, Inc. (OTCQB:GBLX) today announced it has obtained an exclusive license to formulate, manufacture, and sell cannabis-infused oral thin films through its MME-licensed subsidiaries and affiliates GB Sciences Louisiana, …